Endoscopes Market Size to Rake Around US$ 20.4 Bn by 2030

According to Vision Research Reports, the endoscopes market size is expected to be worth around US$ 20.4 billion by 2030 and is predicted to grow at a CAGR of 8.04% from 2021 to 2030.

Endoscopes are medical devices used in endoscopy procedure to observe and treat the internal organs. Endoscopy is minimal invasive procedure in which endoscope is placed inside body either through body openings (mouth, anus etc.) or by making small incisions on the body. Endoscope is equipped with camera allows visualization of internal organs over the video monitor with the help of visualization system. Along with diagnostic purpose, endoscopy also allows sample removal from affected organs (in case of cancer). It is majorly used in surgical procedure as means for minimally invasive surgeries. Endoscopy systems consist of endoscope, visualization system, endo therapy devices, and other devices. Endoscopes has different types based on its applications such as GI endoscopy (for GI tract based applications), arthroscopy (for joints), cystoscopy, hysteroscopy and ureteroscopy (for urology applications), laparoscopy (for various surgeries in pelvic and abdomen area), bronchoscopy (for lungs) laryngoscopy (larynx), and other types that covers various parts. Visualization system consist of the cameras, video processors and convertor, light source, and monitors. Endo therapy devices consist of the endoscopic retrograde cholangiopancreatography devices (ERCP), endoscopic mucosal resection and dissection devices, and ultrasound endoscopes.

Full Report is Ready | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/37523

Growth Factors

The growing awareness regarding the benefits of as compared to open invasive surgeries and the rising prevalence of chronic diseases, such as cancer, heart diseases, and diabetes, are some of the factors driving the market. In addition, technological advancements with respect to endoscopes and the increasing applications in various diagnosis and treatment processes are among the key trends boosting the demand for endoscopes globally.

Increasing incidences of gastrointestinal and other diseases worldwide to drive growth of the endoscopes market

Endoscope are routinely used to diagnose and treat gastrointestinal diseases such as ulcerative colitis, Crohn’s disease, pancreatic, chronic constipation, and other GI tract associated disease. Increasing prevalence of these diseases worldwide are propelling demands for sophisticated endoscope. According to a study published in the Lancet, in October 2017, around 319 (U.S.) and around 322 (Europe) cases of Crohn’s disease per 100,000 people were reported in the mentioned region. According to the journal of Gastroenterology’s on Inflammatory Bowel Disease (IBD) in 2017, around 1.6 million patient in the U.S were suffering from of IBD. Moreover, emerging economies such as China and India are witnessing high prevalence of these disease. For instance, China has high incidence of Inflammatory Bowel Disease with 344 patients per 100,000 population, according to epidemiological study published in 2013, in the Gastroenterology Journal. Increasing prevalence of different type of cancers worldwide are expected to propel growth of the endoscopes market. Gastrointestinal cancer majorly affects stomach and small intestine and it can be effectively treated using endoscope. Increasing prevalence of this cancer is expected to drive growth of the endoscope market. According estimation of American Cancer Society, around 26,240 cases of stomach cancer are estimated to be diagnosed in the U.S. in 2018. This number is even higher for lung and bronchus cancer (234,030 new cases in 2018) and colorectal cancer (140,250)

Report Coverage

Technological advancements in endoscopy procedures are projected to fuel growth of the market

Advanced endoscopy procedures have gained significant traction in recent past, owing to enhanced quality of image visualization, ease of conducting surgical procedures, and availability of personalized features in endoscope. Furthermore, recent advancement in capsule endoscopy integrates capsule shaped endoscope having tiny camera, which is swallowed by patients.

It transmits live images of internal organs, which are visualized over large monitor, which is useful for monitoring and treatment of chronic disease such as cancer and IBD, as it visualizes micro area of internal organs. For instance, Medtronic plc. in 2016, received expanded indication for its Pill Cam COLON 2 capsule endoscope from U.S. Food and Drug Administration (FDA). It is the only non-invasive diagnostic test that directly visualizes the colon for the evaluation of polyps in patients who are at major risks for colonoscopy or moderate sedation. Furthermore, Olympus in June 2017, launched ENDOEYE 3D video endoscope that allows faster and precise endoscopic surgery by using 3D imaging system to facilitate depth perception.

Product Insights

The flexible product segment accounted for the highest revenue share of more than 46.5%of the global market in 2021. It is attributed to its increasing preference by healthcare professionals for the first-line therapeutic option as it can be performed under sedation. The cost-effectiveness, safety, and high-efficiency properties of flexible endoscopes also boost their adoption. In addition, flexible endoscopes are used in several surgical applications, such as gastrointestinal endoscopy, laparoscopy, arthroscopy, urology endoscopy, obstetrics/gynecological endoscopy, bronchoscopy, otoscopy, mediastinoscopy, and laryngoscopy. This increases their adoption and thereby fueling the segment growth.

On the basis of product, the global market has been segmented into rigid, flexible, capsule, disposable, and robot-assisted endoscopes. The disposable endoscopes segment is anticipated to register the fastest growth rate during the forecast period. This growth can be attributed to the increasing preference for these devices over conventional endoscopes to reduce the risk of cross-contamination. In addition, the adoption of disposable devices was higher during the COVID-19 pandemic as these devices reduce the risk of nosocomial disease spread.

Application Insights

The Gastrointestinal (GI) endoscopy application segment dominated the market and accounted for a share of more than 51.5% of the global revenue in 2021. The high share can be attributed to the increased burden of functional gastrointestinal diseases and the rising geriatric population across the globe. In addition, an increase in the number of upper gastrointestinal procedures performed and the growth in the adoption of endoscopes for the treatment and diagnosis of gastrointestinal diseases are also among the key factors driving the segment growth.

On the basis of applications, the global market has been divided into Gastrointestinal (GI) endoscopy, laparoscopy, obstetrics/gynecology endoscopy, arthroscopy, urology endoscopy (cystoscopy), bronchoscopy, mediastinoscopy, otoscopy, laryngoscopy, and other applications. The urology endoscopy application segment is estimated to register the fastest growth rate over the forecast period. This growth can be credited to the increasing prevalence of urologic cancers and the growing volume of urology surgeries. In addition, the growing preference for endoscopic devices for the diagnosis and treatment of urologic disorders is also propelling the segment growth.

End-use Insights

The hospital’s end-user segment dominated the market in 2021 with a revenue share of more than 48%. It is attributed to the increasing product preference among patients for chronic disease treatment. In addition, favorable infrastructure and reimbursement policies also support the segment growth. Moreover, a large number of surgeries are performed in hospitals and it is considered the primary health care system in the majority of the countries. As compared to other healthcare systems, the maximum number of surgeries are performed in the hospitals, which, in turn, boosts the segment growth.

The Ambulatory Surgical Centers (ASCs)/clinics segment is anticipated to grow at the fastest CAGR during the forecast years. Increasing adoption of endoscopes in the ASCs/clinics for the early diagnosis and detection of several life-threatening diseases is supporting the segment growth. In addition, the introduction of keyhole endoscopic surgeries with minimal discomfort and faster recovery time also boosts the segment growth. Moreover, due to shorter stays, lower cost of procedures is further anticipated to augment the segment growth over the forecast years.

Regional Insights

North America led the market in 2021 and accounted for the highest share of more than 41.5% of the global revenue. The regional market is estimated to retain the dominant position throughout the forecast period owing to the increasing adoption of elective endoscopic procedures, improved healthcare expenditure, and the high geriatric population. In addition, the high burden of cancer and functional gastrointestinal disorders in the U.S. is anticipated to further drive the market over the forecast period. For instance, according to the American Cancer Society, about 1.9 million new cancer cases are estimated to be diagnosed in 2021 in the U.S.

On the other hand, Asia Pacific is projected to be the fastest-growing regional market over the forecast period. This growth is owing to the presence of a large patient population pool suffering from functional gastrointestinal disorders. Some of the other factors contributing to the growth of the APAC regional market include the growing geriatric population and improving healthcare infrastructure. In addition, rapid economic development and increasing government healthcare investments are projected to attract foreign investments in this region. Moreover, the presence of key players in APAC is also fueling the adoption of endoscopes, which, in turn, supports the regional market growth.

Key Players

• Olympus Corporation
• PENTAX Medical
• Ethicon US, LLC
• FUJIFILM Holdings Corporation
• Stryker
• Boston Scientific Corporation
• CONMED Corporation
• Karl Storz GmbH & Co., KG
• Richard Wolf Medical Instruments
• Medtronic

Market Segmentation

• Product Outlook
  • Rigid Endoscopes
    • Laparoscopes
    • Arthroscopes
    • Urology Endoscopes
    • Cystoscopes
    • Gynecology Endoscopes
    • Neuroendoscopes
    • Other Rigid Endoscopes
  • Flexible Endoscopes
    • Upper Gastrointestinal Endoscopes
    • Colonoscopes
    • Bronchoscopes
    • Sigmoidoscopes
    • Laryngoscopes
    • Pharyngoscopes
    • Duodenoscopes
    • Nasopharyngoscopes
    • Rhinoscopes
    • Other Flexible Endoscopes
  • Capsule Endoscopes
  • Disposable Endoscopes
  • Robot Assisted Endoscopes
• Application Outlook
  • Gastrointestinal (GI) Endoscopy
  • Laparoscopy
  • Obstetrics/Gynecology Endoscopy
  • Arthroscopy
  • Urology Endoscopy (Cystoscopy)
  • Bronchoscopy
  • Mediastinoscopy
  • Otoscopy
  • Laryngoscopy
  • Other Applications
• End-use Outlook
  • Hospitals
  • Ambulatory Surgery Centers/Clinics
  • Other End Uses
• Regional Outlook
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Click Here to View Full Report Table of Contents

Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/37523

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333